Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Treasury Shares (2021 - 2025)

Historic Treasury Shares for Inspire Medical Systems (INSP) over the last 5 years, with Q4 2025 value amounting to $1.1 million.

  • Inspire Medical Systems' Treasury Shares rose 5622.64% to $1.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.1 million, marking a year-over-year increase of 5622.64%. This contributed to the annual value of $1.1 million for FY2025, which is 5622.64% up from last year.
  • Per Inspire Medical Systems' latest filing, its Treasury Shares stood at $1.1 million for Q4 2025, which was up 5622.64% from $985708.0 recorded in Q3 2025.
  • Over the past 5 years, Inspire Medical Systems' Treasury Shares peaked at $1.1 million during Q4 2025, and registered a low of $2275.0 during Q1 2021.
  • In the last 5 years, Inspire Medical Systems' Treasury Shares had a median value of $188402.0 in 2023 and averaged $372969.6.
  • Its Treasury Shares has fluctuated over the past 5 years, first soared by 538043.96% in 2022, then skyrocketed by 5622.64% in 2025.
  • Quarter analysis of 5 years shows Inspire Medical Systems' Treasury Shares stood at $2275.0 in 2021, then surged by 5380.44% to $124680.0 in 2022, then soared by 61.27% to $201070.0 in 2023, then skyrocketed by 238.14% to $679905.0 in 2024, then soared by 56.23% to $1.1 million in 2025.
  • Its Treasury Shares was $1.1 million in Q4 2025, compared to $985708.0 in Q3 2025 and $1.0 million in Q2 2025.